How can I choose the best treatment of myelodysplastic syndrome?

The best treatment of myelodysplastic syndrome syndrome often varies depending on several different factors that affect the patient's needs. Younger patients in good health may be more suitable for more aggressive treatment to slow down or stop the disease. Others may only have supportive care, such as transfusions or antibiotics that treat the effects of syndrome and improve the quality of life. Those with less serious forms of the disease may only require supportive care options.

One option to treat myelodysplastic syndrome syndrome, which can have very good results for some people, chemotherapy followed by bone marrow transplantation. Chemotherapy is used to kill non -functional bone marrow cells, and then the cells of the corresponding donor are used to replace them. In some patients, this technique was able to cure the disease; Most cases are incurable. For others he is able to significantly slow his progress. The procedure is difficult and rioblola is often usedAnd only in patients who are young and strong, or those who have very aggressive types of myelodysplastic syndrome.

patients in whom chemotherapy and transplantation are inappropriate usually receive supportive care to help alleviate the negative effects of the disease. One of the important types of supportive treatment of myelodysplastic syndrome is blood transfusion. The disease destroys blood cells and affects the body's ability to create more, so anemia is often a problem for these patients. Transfusion can help replace the blood that has been lost and to fight the effects of anemia.

The use of growth factors is another treatment of myelodysplastic syndrome for solving anemia. Growth factors are substances that stimulate red blood cell production. The type of growth factor, which is usually used with this disease, is called erythropoetin.

Several drugs are alv some cases is considered alreadyIT FOR TREATMENT OF THE MYLODYSPLASTIC SYNDROME. Drugs such as lenalidomide and antithymocyte globulin can help fight anemia and reduce the need for blood transfusions in patients with specific forms of the disease. Patients who receive transfusions may need deferoxamine to help fight iron accumulation in their blood and tissues. Some patients may be susceptible to the development of leukemia; Medicines such as azacitidine and decitabine may be taken to postpone or stop. People with myelodysplastic syndrome may be susceptible to infection and may also require antibiotic treatment.